Towards Healthcare
Pleural Biopsy Market Size to Reach USD 594.6 Million by 2034

Pleural Biopsy Market Growth 2025 to 2034 Key Players, AI Adoption & Global Forecast

Based on market forecasts, the pleural biopsy sector will expand from USD 329.03 million in 2024 to USD 594.6 million by 2034, experiencing a CAGR of 6.14%. The pleural biopsy market is expanding due to rising demand for pleural diagnostics as well as increasing use of video-assisted thoracoscopic surgery. North America led the market due to the growing adoption of thoracoscopic biopsies.

  • Insight Code: 5954
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The pleural biopsy market is projected to reach USD 594.6 million by 2034, growing at a CAGR of 6.14% from 2024 to 2034.

North America is currently leading the pleural biopsy market due to the growing adoption of thoracoscopic biopsies.

The pleural biopsy market includes 5 segments such as by technique type, by application/disease type, by product type, by end user, and by region.

Some key players include Olympus Corporation, Medtronic plc, Boston Scientific Corporation, and Cook Medical, Inc. 

Pleural biopsy focuses on the collection and analysis of pleural tissue samples to diagnose diseases affecting the pleura, which is a thin membrane surrounding the lungs and lining the chest cavity.

Pleural biopsies are used for the identification of malignant pleural mesothelioma, metastatic cancers, tuberculosis (TB), empyema, and other pleural pathologies.

CDC, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB.